Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The use of corticosteroids is not permitted nor advised due to known severe interactions with this product.
Use tacrolimus per pharmacy label.
Ondansetron is not permitted nor advised due to known severe interactions with this product.
Use phergan or reglan per pharmacy label.
Dobutamine is not permitted nor advised due to known severe interactions with this product
Use dopamine per pharmacy label.
Salicylates are not permitted nor advised due to known severe interactions with this product.
Use acetaminophen/paracetamol per pharmacy label.
SGLT-2 inhibitors are not permitted nor advised due to known severe interactions with this product.
Use DPP-4 inhibitors per pharmacy label.
Confusion and altered mental status may occur if patient is febrile. Assessment of mental status is recommended per institutional policy if signs are noted.
Fatigue and loss of appetite is anticipated as part of the clinical trial product administration. Encourage rest and ingestion of clear liquids or solids as tolerated.
Targeted neurological assessment every hour while inpatient is recommended.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.